BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37489929)

  • 1. Unusual Presentation of
    Nathani A; Tauquir A; Khan S; Arrossi AV; Almeida F
    Am J Respir Crit Care Med; 2023 Dec; 208(11):e44-e46. PubMed ID: 37489929
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis jirovecii Pneumonia.
    Catherinot E; Lanternier F; Bougnoux ME; Lecuit M; Couderc LJ; Lortholary O
    Infect Dis Clin North Am; 2010 Mar; 24(1):107-38. PubMed ID: 20171548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution inflammatory syndrome in a non-HIV immunocompromised patient with Pneumocystis Jirovecii pneumonia.
    Libardo RP; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13856. PubMed ID: 35598073
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypercalcaemia in an immunocompromised patient: consider Pneumocystis jirovecii pneumonia.
    Bromley K; Phillips J; Irish A
    Med J Aust; 2022 Nov; 217(10):517-518. PubMed ID: 36263984
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.
    Bhat P; Noval M; Doub JB; Heil E
    Int J Infect Dis; 2020 Oct; 99():119-121. PubMed ID: 32768700
    [No Abstract]   [Full Text] [Related]  

  • 6. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
    Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
    Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positive Pneumocystis jirovecii PCR in immunocompromised patients with a systemic disease: infection or colonisation?].
    Mekinian A; Queyrel V; Durand-Joly I; Moranne O; Denis G; Delhaes L; Morell-Dubois S; Lambert M; Launay D; Hachulla E; Hatron PY
    Rev Med Interne; 2010 Mar; 31(3):194-9. PubMed ID: 20045225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.
    Baumann S; Reinwald M; Haghi D; Hofmann WK; Buchheidt D
    Onkologie; 2013; 36(10):582-4. PubMed ID: 24107913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal Pneumocystis jirovecii pneumonia in a non-immunocompromised patient with alcohol-related liver cirrhosis.
    Hadfield NJ; Selvendran S; Johnston MP
    Scott Med J; 2019 Nov; 64(4):148-153. PubMed ID: 31474180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Pneumocystis jirovecii Infection with Osteomyelitis in a Patient with CTLA-4 Haploinsufficiency.
    Siddiqi AE; Liu AY; Charville GW; Kunder CA; Uzel G; Sadighi Akha AA; Oak J; Martin B; Sacha J; Lewis DB; Gernez Y
    J Clin Immunol; 2020 Feb; 40(2):412-414. PubMed ID: 31955317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Investigation of Pneumocystis jirovecii in Respiratory Samples of Immunocompromised Patients with PCR, IFA and Giemsa Staining Methods].
    Tosun I; Buruk K; Dede R; Kaklıkaya N
    Mikrobiyol Bul; 2013 Jan; 47(1):195-7. PubMed ID: 23390920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.
    Finkelman MA
    Crit Rev Microbiol; 2010 Nov; 36(4):271-81. PubMed ID: 20854193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis infection in humans: diagnosis and treatment.
    Calderón EJ; Gutiérrez-Rivero S; Durand-Joly I; Dei-Cas E
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):683-701. PubMed ID: 20521896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a fully automated PCR assay for the detection of Pneumocystis jirovecii using the GENECUBE system.
    Matsumura Y; Tsuchido Y; Yamamoto M; Nakano S; Nagao M
    Med Mycol; 2019 Oct; 57(7):841-847. PubMed ID: 30590702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous resolution of Pneumocystis jirovecii pneumonia on high-resolution computed tomography in a patient with renal cell carcinoma.
    Tanaka Y; Saraya T; Kurai D; Ishii H; Takizawa H; Goto H
    Am J Case Rep; 2014 Nov; 15():496-500. PubMed ID: 25396336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation.
    Trubin PA; Azar MM
    Infect Dis Clin North Am; 2023 Sep; 37(3):617-640. PubMed ID: 37142510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia.
    Das CK; Mirdha BR; Singh S; Seth R; Bagga A; Lodha R; Kabra SK
    J Trop Pediatr; 2014 Jun; 60(3):216-22. PubMed ID: 24425204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of Pneumocystis jirovecii DNA detection by real-time PCR in hematological patient respiratory specimens.
    Piñana JL; Albert E; Gómez MD; Pérez A; Hernández-Boluda JC; Montoro J; Salavert M; González EM; Tormo M; Giménez E; Villalba M; Balaguer-Roselló A; Hernani R; Bueno F; Borrás R; Sanz J; Solano C; Navarro D
    J Infect; 2020 May; 80(5):578-606. PubMed ID: 31926954
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
    Rogina P; Skvarc M
    Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.